456
Views
1
CrossRef citations to date
0
Altmetric
Review

Semaphorin 4D as a guidance molecule in the immune system

ORCID Icon
Pages 268-273 | Received 29 Jan 2021, Accepted 13 Mar 2021, Published online: 31 Mar 2021

References

  • Semaphorin Nomenclature Committee. Unified nomenclature for the semaphorins/collapsins. Cell. 1999;97:551–552.
  • Swiercz JM, Kuner R, Behrens J, Offermanns S. Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron. 2002;35(1):51–63. doi:10.1016/S0896-6273(02)00750-X.
  • Ito Y, Oinuma I, Katoh H, et al. Sema4D/plexin-B1 activates GSK-3beta through R-Ras GAP activity, inducing growth cone collapse. EMBO Rep. 2006;7(7):704–709. doi:10.1038/sj.embor.7400737.
  • Wang X, Kumanogoh A, Watanabe C, et al. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood. 2001;97(11):3498–3504. doi:10.1182/blood.v97.11.3498.
  • Kumanogoh A, Suzuki K, Ch’ng E, et al. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J Immunol. 2002;169(3):1175–1181. doi:10.4049/jimmunol.169.3.1175.
  • Conrotto P, Valdembri D, Corso S, et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood. 2005;105(11):4321–4329. doi:10.1182/blood-2004-07-2885.
  • Negishi-Koga T, Shinohara M, Komatsu N, et al. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat Med. 2011;17(11):1473–1480. doi:10.1038/nm.2489.
  • Bougeret C, Mansur IG, Dastot H, et al. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol. 1992;148:318–323.
  • Hall KT, Boumsell L, Schultze JL, et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA. 1996;93(21):11780–11785. doi:10.1073/pnas.93.21.11780.
  • Kumanogoh A, Watanabe C, Lee I, et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity. 2000;13(5):621–631. doi:10.1016/S1074-7613(00)00062-5.
  • Ishida I, Kumanogoh A, Suzuki K, et al. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses. Int Immunol. 2003;15(8):1027–1034. doi:10.1093/intimm/dxg098.
  • Galuppo MK, de Rezende E, Forti FL, et al. CD100/Sema4D increases macrophage infection by Leishmania (Leishmania) amazonensis in a CD72 dependent manner. Front Microbiol. 2018;9:1177.
  • Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp J, et al. Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol. 2005;17(4):439–447. doi:10.1093/intimm/dxh224.
  • Toguchi M, Gonzalez D, Furukawa S, Inagaki S. Involvement of Sema4D in the control of microglia activation. Neurochem Int. 2009;55(7):573–580. doi:10.1016/j.neuint.2009.05.013.
  • Yan H, Wu L, Shih C, et al. Plexin B2 and semaphorin 4C guide T cell recruitment and function in the germinal center. Cell Rep. 2017;19(5):995–1007. doi:10.1016/j.celrep.2017.04.022.
  • Kuklina EM, Nekrasova IV. New aspects of the Seam4D-dependent control of lymphocyte activation. Dokl Biol Sci. 2017;473(1):84–88. doi:10.1134/S0012496617020028.
  • Delaire S, Billard C, Tordjman R, et al. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol. 2001;166(7):4348–4354. doi:10.4049/jimmunol.166.7.4348.
  • Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 1999;99(1):71–80. doi:10.1016/s0092-8674(00)80063-x.
  • Witherden A, Watanabe M, Garijo O, et al. The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function. Immunity. 2012;37(2):314–325. doi:10.1016/j.immuni.2012.05.026.
  • Deng S, Hirschberg A, Worzfeld T, et al. Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo. J Neurosci. 2007;27(23):6333–6347. doi:10.1523/JNEUROSCI.5381-06.2007.
  • Saito Y, Oinuma I, Fujimoto S, Negishi M. Plexin-B1 is a GTPase activating protein for M-Ras, remodelling dendrite morphology. EMBO Rep. 2009;10(6):614–621. doi:10.1038/embor.2009.63.
  • Hall A, Lalli G. Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb Perspect Biol. 2010;2:1–18.
  • Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 2001;22(1):32–39. doi:10.1016/S0165-6147(00)01596-0.
  • Arimura N, Inagaki N, Chihara K, et al. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem. 2000;275(31):23973–23980. doi:10.1074/jbc.M001032200.
  • McColl B, Garg R, Riou P, et al. Rnd3-induced cell rounding requires interaction with Plexin-B2. J Cell Sci. 2016;129(21):4046–4056. doi:10.1242/jcs.192211.
  • Wylie T, Garg R, Ridley AJ, Conte MR. Analysis of the interaction of Plexin-B1 and Plexin-B2 with Rnd family proteins. PLoS One. 2017;12(10):e0185899. doi:10.1371/journal.pone.0185899.
  • Oinuma I, Katoh H, Harada A, Negishi M. Direct interaction of Rnd1 with Plexin-B1 regulates PDZ-RhoGEF-mediated Rho activation by Plexin-B1 and induces cell contraction in COS-7 cells. J Biol Chem. 2003;278(28):25671–25777. doi:10.1074/jbc.M303047200.
  • Swiercz JM, Worzfeld T, Offermanns S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J Biol Chem. 2008;283(4):1893–1901. doi:10.1074/jbc.M706822200.
  • Franco M, Tamagnone L. Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive. EMBO Rep. 2008;9(9):865–871. doi:10.1038/embor.2008.139.
  • Basile JR, Afkhami JR, Afkhami T, Gutkind JS. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol. 2005;25(16):6889–6898. doi:10.1128/MCB.25.16.6889-6898.2005.
  • Giacobini P, Messina A, Morello F, et al. Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex. J Cell Biol. 2008;183(3):555–566. doi:10.1083/jcb.200806160.
  • Giordano S, Corso S, Conrotto P, et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol. 2002;4(9):720–724. doi:10.1038/ncb843.
  • Oinuma I, Katoh H, Negishi M. Semaphorin 4D/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating beta(1) integrin activity. J Cell Biol. 2006;173(4):601–613. doi:10.1083/jcb.200508204.
  • Smith P, Shanks K, Lipsky M, et al. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol. 2011;12:30. doi:10.1186/1471-2172-12-30.
  • Okuno T, Nakatsuji Y, Moriya M, et al. Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2010;184(3):1499–1506. doi:10.4049/jimmunol.0903302.
  • Luque MC, Gutierrez PS, Debbas V, et al. CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis. Mol Immunol. 2015;67(2 Pt B):559–567. doi:10.1016/j.molimm.2015.07.028.
  • Roney K, O’Connor B, Wen H, et al. Plexin-B2 negatively regulates macrophage motility, Rac, and Cdc42 activation. PLoS One. 2011;6(9):e24795. doi:10.1371/journal.pone.0024795.
  • Holl EK, Roney KE, Allen IC, et al. Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production. PLoS One. 2012;7(8):e43333. doi:10.1371/journal.pone.0043333.
  • Yu D, Cook MC, Shin DM, et al. Axon growth and guidance genes identify T-dependent germinal centre B cells. Immunol Cell Biol. 2008;86(1):3–14. doi:10.1038/sj.icb.7100123.
  • Walzer T, Galibert L, De Smedt T. Dendritic cell function in mice lacking Plexin C1. Int Immunol. 2005;17(7):943–950. doi:10.1093/intimm/dxh274.
  • Ke Y, Dang E, Shen S, et al. Semaphorin4D drives CD8+ T-cell lesional trafficking in oral lichen planus via CXCL9/CXCL10 upregulations in oral keratinocytes. J Invest Dermatol. 2017;137(11):2396–2406. doi:10.1016/j.jid.2017.07.818.
  • Evans E, Jonason S, Bussler H, et al. Antibody blockade of semaphorin 4D promotes immune infiltration into tumor and enhances response to other immunomodulatory therapies. Cancer Immunol Res. 2015;3(6):689–701. doi:10.1158/2326-6066.CIR-14-0171.
  • Worzfeld T, Swiercz M, Looso M, et al. ErbB-2 signals through plexin-B1 to promote breast cancer metastasis. J Clin Invest. 2012;122(4):1296–1305. doi:10.1172/JCI60568.
  • Valente G, Nicotra G, Arrondini M, et al. Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression. Cell Oncol. 2009;31(6):423–436. doi:10.3233/CLO-2009-0504.
  • Liu H, Yang Y, Xiao J, et al. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Microvasc Res. 2014;93:1–8. doi:10.1016/j.mvr.2014.02.007.
  • Campos M, Campos G, Ribeiro G, et al. Ki-67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively. Oncol Lett. 2013;5(5):1527–1535. doi:10.3892/ol.2013.1226.
  • Zhou H, Kann G, Mallory K, et al. Recruitment of Tiam1 to semaphorin 4D activates rac and enhances proliferation, invasion, and metastasis in oral squamous cell carcinoma. Neoplasia. 2017;19(2):65–74. doi:10.1016/j.neo.2016.12.004.
  • Basile R, Castilho M, Williams P, Gutkind S. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA. 2006;103(24):9017–9022. doi:10.1073/pnas.0508825103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.